chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Product administered at inappropriate site, Vaccination site pain
Clinical narrative: Nausea; Dizzy; Face Hot; Trouble breathing/chest tightness; Trouble breathing/chest tightness; 1hr pain to shot; administered in right leg; This is a spontaneous report received from a contactable hcp (patient). A 67-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration administered in right leg on 15Mar2021 09:30 (Batch/Lot Number: EN6204) as single dose for COVID-19 immunization. Medical history included known allergy, asthma, atrial fibrillation, urticaria. Concomitant medications included cetirizine hydrochloride (ZYRTEC) as pre treated; diphenhydramine hydrochloride (BENADRYL) as pre treated. The patient previously received the first dose of BNT162B2 (Batch/Lot number: EN6200) on 20Feb2021 13:00 in left leg by injection for COVID-19 immunization. The patient experienced nausea, dizzy, face hot, trouble breathing/chest tightness, pain to shot, all on 15Mar2021. Clinical course: Pre treated u/ 50mg Benadryl and 1 Zyrtec. 1hr pain to shot. u/in 15 minutes of shot: Nausea, dizzy, face hot, trouble breathing/chest tightness, given oxygen +2 more Benadryl laid down u/ feet up, discharged 1200HR Sx resolved by next day (24hours). The outcome of the events was recovered on 16Mar2021.   No follow-up attempts are needed. No further information is expected.; Sender's Comments: There is a reasonable possibility that the events nausea and vaccination site pain were related to BNT162b2 based on known drug safety profile. Based on the temporal relationship, the association between the events "face hot, trouble breathing/chest tightness" with BNT162b2 can not be completely excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Dyspnoea, Swollen tongue
Clinical narrative: couldn't concentrate, think, read, be productive, sort papers etc. spent 3 days in bed; couldn't concentrate, think, read, be productive, sort papers etc. spent 3 days in bed; labored breathing / Breathing difficult; swelling face; swelling face, mouth, tongue/my skull was swelling; swelling face, mouth, tongue/my skull was swelling; swelling face, mouth, tongue/my skull was swelling; Dizzy; weak; This is a spontaneous report from a contactable consumer, the patient. A 74-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot ER8727, second dose) solution for injection intramuscular in the left arm on 22Mar2021 at 09:00 (at the age of 74-years-old) as a single dose for COVID-19 vaccination. The patient was not pregnant at the time of vaccination. Medical history included known allergies: sulfa drugs. There were no concomitant medications. Historical vaccine included BNT162B2 (first dose, lot EN6198) for COVID-19 vaccination on 01Mar2021 and experienced nausea, dizzy, weak, feeling unwell, and sore arm at injection site. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 22Mar2021 at 09:30, the patient experienced labored breathing, swelling face, mouth, tongue/my skull was swelling, out of breath with little exertion, dizzy, and weak. On 23Mar2021, the patient couldn't concentrate, think, read, be productive, sort papers etc. spent 3 days in bed. The events resulted in emergency room/department or urgent care. Treatment for the events included EPIPEN, steroids, ZYRTEC, famotidine. The outcome of the events was recovering. The patient was not test for COVID post vaccination.
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Disturbance in attention, Dizziness, Dyspnoea, Impaired work ability
Clinical narrative: couldn't concentrate, think, read, be productive, sort papers etc. spent 3 days in bed; couldn't concentrate, think, read, be productive, sort papers etc. spent 3 days in bed; labored breathing / Breathing difficult; swelling face; swelling face, mouth, tongue/my skull was swelling; swelling face, mouth, tongue/my skull was swelling; swelling face, mouth, tongue/my skull was swelling; Dizzy; weak; This is a spontaneous report from a contactable consumer, the patient. A 74-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot ER8727, second dose) solution for injection intramuscular in the left arm on 22Mar2021 at 09:00 (at the age of 74-years-old) as a single dose for COVID-19 vaccination. The patient was not pregnant at the time of vaccination. Medical history included known allergies: sulfa drugs. There were no concomitant medications. Historical vaccine included BNT162B2 (first dose, lot EN6198) for COVID-19 vaccination on 01Mar2021 and experienced nausea, dizzy, weak, feeling unwell, and sore arm at injection site. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 22Mar2021 at 09:30, the patient experienced labored breathing, swelling face, mouth, tongue/my skull was swelling, out of breath with little exertion, dizzy, and weak. On 23Mar2021, the patient couldn't concentrate, think, read, be productive, sort papers etc. spent 3 days in bed. The events resulted in emergency room/department or urgent care. Treatment for the events included EPIPEN, steroids, ZYRTEC, famotidine. The outcome of the events was recovering. The patient was not test for COVID post vaccination.
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Mouth swelling, Swelling, Swelling face, Swollen tongue
Clinical narrative: couldn't concentrate, think, read, be productive, sort papers etc. spent 3 days in bed; couldn't concentrate, think, read, be productive, sort papers etc. spent 3 days in bed; labored breathing / Breathing difficult; swelling face; swelling face, mouth, tongue/my skull was swelling; swelling face, mouth, tongue/my skull was swelling; swelling face, mouth, tongue/my skull was swelling; Dizzy; weak; This is a spontaneous report from a contactable consumer, the patient. A 74-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot ER8727, second dose) solution for injection intramuscular in the left arm on 22Mar2021 at 09:00 (at the age of 74-years-old) as a single dose for COVID-19 vaccination. The patient was not pregnant at the time of vaccination. Medical history included known allergies: sulfa drugs. There were no concomitant medications. Historical vaccine included BNT162B2 (first dose, lot EN6198) for COVID-19 vaccination on 01Mar2021 and experienced nausea, dizzy, weak, feeling unwell, and sore arm at injection site. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 22Mar2021 at 09:30, the patient experienced labored breathing, swelling face, mouth, tongue/my skull was swelling, out of breath with little exertion, dizzy, and weak. On 23Mar2021, the patient couldn't concentrate, think, read, be productive, sort papers etc. spent 3 days in bed. The events resulted in emergency room/department or urgent care. Treatment for the events included EPIPEN, steroids, ZYRTEC, famotidine. The outcome of the events was recovering. The patient was not test for COVID post vaccination.
Age: 24.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Blindness, Deafness, Palpitations
Clinical narrative: Per patient she experiences anxiety and panick attacks in any medical setting signs included and exhibited were vision loss, hearing loss sweating, heart palpitations, after arrival of EMS patient vomited. Refused hospital transport.
Age: 24.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Anxiety, Blindness, Deafness, Hyperhidrosis, Palpitations
Clinical narrative: Per patient she experiences anxiety and panick attacks in any medical setting signs included and exhibited were vision loss, hearing loss sweating, heart palpitations, after arrival of EMS patient vomited. Refused hospital transport.
Age: 24.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Panic attack, Vomiting
Clinical narrative: Per patient she experiences anxiety and panick attacks in any medical setting signs included and exhibited were vision loss, hearing loss sweating, heart palpitations, after arrival of EMS patient vomited. Refused hospital transport.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Exposure during pregnancy, Foetal death, Haematocrit decreased, Haemoglobin decreased, Induced labour
Clinical narrative: Patient was a 33 yo gravita 2 para 0010 (1 prior miscarriage) who experienced a stillbirth at 26 weeks and 4 days of pregnancy, two weeks after receiving her first dose of the covid-19 vaccine.  The placental findings demonstrate a maternal floor infarct
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Mean cell haemoglobin concentration decreased, Mean cell haemoglobin decreased, Mean cell volume normal, Mean platelet volume increased, Nucleated red cells
Clinical narrative: Patient was a 33 yo gravita 2 para 0010 (1 prior miscarriage) who experienced a stillbirth at 26 weeks and 4 days of pregnancy, two weeks after receiving her first dose of the covid-19 vaccine.  The placental findings demonstrate a maternal floor infarct
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Platelet count normal, Red blood cell count normal, Red cell distribution width increased, Stillbirth, White blood cell count normal
Clinical narrative: Patient was a 33 yo gravita 2 para 0010 (1 prior miscarriage) who experienced a stillbirth at 26 weeks and 4 days of pregnancy, two weeks after receiving her first dose of the covid-19 vaccine.  The placental findings demonstrate a maternal floor infarct
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Foetal death
Clinical narrative: Patient was a 33 yo gravita 2 para 0010 (1 prior miscarriage) who experienced a stillbirth at 26 weeks and 4 days of pregnancy, two weeks after receiving her first dose of the covid-19 vaccine.  The placental findings demonstrate a maternal floor infarct
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Exposure during pregnancy, Infarction, Stillbirth
Clinical narrative: Patient was a 33 yo gravita 2 para 0010 (1 prior miscarriage) who experienced a stillbirth at 26 weeks and 4 days of pregnancy, two weeks after receiving her first dose of the covid-19 vaccine.  The placental findings demonstrate a maternal floor infarct
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anaphylactic reaction, Blood pressure increased, Blood pressure measurement, Feeling abnormal, Heart rate
Clinical narrative: had a mild allergy after the first dose; This is a spontaneous report from a Pfizer-sponsored program. A contactable female consumer (patient) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: unknown), via an unspecified route of administration on 01Mar2021 as single dose for COVID-19 immunization. Patient's concomitant medication and medical history were not reported. The patient reported that she had mild allergy after the first dose. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Heart rate increased, Hypoaesthesia oral
Clinical narrative: had a mild allergy after the first dose; This is a spontaneous report from a Pfizer-sponsored program. A contactable female consumer (patient) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: unknown), via an unspecified route of administration on 01Mar2021 as single dose for COVID-19 immunization. Patient's concomitant medication and medical history were not reported. The patient reported that she had mild allergy after the first dose. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypersensitivity
Clinical narrative: had a mild allergy after the first dose; This is a spontaneous report from a Pfizer-sponsored program. A contactable female consumer (patient) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: unknown), via an unspecified route of administration on 01Mar2021 as single dose for COVID-19 immunization. Patient's concomitant medication and medical history were not reported. The patient reported that she had mild allergy after the first dose. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test normal, Hypertensive urgency
Clinical narrative: Pt felt unwell beginning the day of vaccine, worse the subsequent day and intermittently over the next 9d.  On 3/26 went to periodontist, BP found to be >200.  Saw me (PCP) later that day, BP confirmed 200/110 and 210/116.   Sent to ED.  Admitted overnight, cardiac status evaluated, given IV and oral meds to lower BP. Sent home on valsartan and chlorthalidone.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure increased, Chest X-ray, Electrocardiogram, Laboratory test, Malaise
Clinical narrative: Pt felt unwell beginning the day of vaccine, worse the subsequent day and intermittently over the next 9d.  On 3/26 went to periodontist, BP found to be >200.  Saw me (PCP) later that day, BP confirmed 200/110 and 210/116.   Sent to ED.  Admitted overnight, cardiac status evaluated, given IV and oral meds to lower BP. Sent home on valsartan and chlorthalidone.
Age: 45.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Abdominal pain, Blood test, Computerised tomogram abdomen abnormal, Computerised tomogram pelvis, Malaise
Clinical narrative: Pt "I have been having abd pain since Monday. I got my second shot for COIVD on Friday. I thought maybe I pulled a muscle from all the vomiting. It started uptop but now it is moved further down" Pt c/o SOB  ? Shortness of Breath This is a 45 y.o. male presenting today for evaluation of abdominal pain.  Patient says that he received his Covid-19 vaccine last Friday and he started to have symptoms.  He said that he at first was very tired and this progressed into abdominal pain, nausea and vomiting.  He also notes that he was having Taylor stools.  He says that he has not been eating as well.  He says that he has been nauseous much of this week and he started to have worsening abdominal pain in his upper abdomen down into his lower abdomen.  He denies any medical history other than high blood pressure which is not currently treated.  No history of any abdominal surgeries.  Patient denies any association with food
Age: 45.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Mesenteric vein thrombosis, Nausea, Oedematous pancreatitis, Portal vein thrombosis
Clinical narrative: Pt "I have been having abd pain since Monday. I got my second shot for COIVD on Friday. I thought maybe I pulled a muscle from all the vomiting. It started uptop but now it is moved further down" Pt c/o SOB  ? Shortness of Breath This is a 45 y.o. male presenting today for evaluation of abdominal pain.  Patient says that he received his Covid-19 vaccine last Friday and he started to have symptoms.  He said that he at first was very tired and this progressed into abdominal pain, nausea and vomiting.  He also notes that he was having Taylor stools.  He says that he has not been eating as well.  He says that he has been nauseous much of this week and he started to have worsening abdominal pain in his upper abdomen down into his lower abdomen.  He denies any medical history other than high blood pressure which is not currently treated.  No history of any abdominal surgeries.  Patient denies any association with food
Age: 45.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Abdominal pain, Abnormal faeces, Bundle branch block right, Computerised tomogram abdomen, Decreased appetite
Clinical narrative: Pt "I have been having abd pain since Monday. I got my second shot for COIVD on Friday. I thought maybe I pulled a muscle from all the vomiting. It started uptop but now it is moved further down" Pt c/o SOB  ? Shortness of Breath This is a 45 y.o. male presenting today for evaluation of abdominal pain.  Patient says that he received his Covid-19 vaccine last Friday and he started to have symptoms.  He said that he at first was very tired and this progressed into abdominal pain, nausea and vomiting.  He also notes that he was having Taylor stools.  He says that he has not been eating as well.  He says that he has been nauseous much of this week and he started to have worsening abdominal pain in his upper abdomen down into his lower abdomen.  He denies any medical history other than high blood pressure which is not currently treated.  No history of any abdominal surgeries.  Patient denies any association with food
Age: 45.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Dyspnoea, Electrocardiogram normal, Fatigue, Lipase normal, Muscle strain
Clinical narrative: Pt "I have been having abd pain since Monday. I got my second shot for COIVD on Friday. I thought maybe I pulled a muscle from all the vomiting. It started uptop but now it is moved further down" Pt c/o SOB  ? Shortness of Breath This is a 45 y.o. male presenting today for evaluation of abdominal pain.  Patient says that he received his Covid-19 vaccine last Friday and he started to have symptoms.  He said that he at first was very tired and this progressed into abdominal pain, nausea and vomiting.  He also notes that he was having Taylor stools.  He says that he has not been eating as well.  He says that he has been nauseous much of this week and he started to have worsening abdominal pain in his upper abdomen down into his lower abdomen.  He denies any medical history other than high blood pressure which is not currently treated.  No history of any abdominal surgeries.  Patient denies any association with food
Age: 45.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Nausea, Oedema, Scan with contrast abnormal, Thrombosis, Vomiting
Clinical narrative: Pt "I have been having abd pain since Monday. I got my second shot for COIVD on Friday. I thought maybe I pulled a muscle from all the vomiting. It started uptop but now it is moved further down" Pt c/o SOB  ? Shortness of Breath This is a 45 y.o. male presenting today for evaluation of abdominal pain.  Patient says that he received his Covid-19 vaccine last Friday and he started to have symptoms.  He said that he at first was very tired and this progressed into abdominal pain, nausea and vomiting.  He also notes that he was having Taylor stools.  He says that he has not been eating as well.  He says that he has been nauseous much of this week and he started to have worsening abdominal pain in his upper abdomen down into his lower abdomen.  He denies any medical history other than high blood pressure which is not currently treated.  No history of any abdominal surgeries.  Patient denies any association with food
Age: 45.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: White blood cell count increased
Clinical narrative: Pt "I have been having abd pain since Monday. I got my second shot for COIVD on Friday. I thought maybe I pulled a muscle from all the vomiting. It started uptop but now it is moved further down" Pt c/o SOB  ? Shortness of Breath This is a 45 y.o. male presenting today for evaluation of abdominal pain.  Patient says that he received his Covid-19 vaccine last Friday and he started to have symptoms.  He said that he at first was very tired and this progressed into abdominal pain, nausea and vomiting.  He also notes that he was having Taylor stools.  He says that he has not been eating as well.  He says that he has been nauseous much of this week and he started to have worsening abdominal pain in his upper abdomen down into his lower abdomen.  He denies any medical history other than high blood pressure which is not currently treated.  No history of any abdominal surgeries.  Patient denies any association with food
Age: 45.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Abdominal pain lower, Abdominal pain upper, Activated partial thromboplastin time shortened, Anticoagulant therapy, Computerised tomogram abdomen
Clinical narrative: Pt "I have been having abd pain since Monday. I got my second shot for COIVD on Friday. I thought maybe I pulled a muscle from all the vomiting. It started uptop but now it is moved further down" Pt c/o SOB  ? Shortness of Breath This is a 45 y.o. male presenting today for evaluation of abdominal pain.  Patient says that he received his Covid-19 vaccine last Friday and he started to have symptoms.  He said that he at first was very tired and this progressed into abdominal pain, nausea and vomiting.  He also notes that he was having Taylor stools.  He says that he has not been eating as well.  He says that he has been nauseous much of this week and he started to have worsening abdominal pain in his upper abdomen down into his lower abdomen.  He denies any medical history other than high blood pressure which is not currently treated.  No history of any abdominal surgeries.  Patient denies any association with food
Age: 45.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Computerised tomogram abnormal, Factor V Leiden mutation, Fatigue, Haematocrit normal, Haemoglobin normal
Clinical narrative: Pt "I have been having abd pain since Monday. I got my second shot for COIVD on Friday. I thought maybe I pulled a muscle from all the vomiting. It started uptop but now it is moved further down" Pt c/o SOB  ? Shortness of Breath This is a 45 y.o. male presenting today for evaluation of abdominal pain.  Patient says that he received his Covid-19 vaccine last Friday and he started to have symptoms.  He said that he at first was very tired and this progressed into abdominal pain, nausea and vomiting.  He also notes that he was having Taylor stools.  He says that he has not been eating as well.  He says that he has been nauseous much of this week and he started to have worsening abdominal pain in his upper abdomen down into his lower abdomen.  He denies any medical history other than high blood pressure which is not currently treated.  No history of any abdominal surgeries.  Patient denies any association with food
Age: 45.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Headache, International normalised ratio increased, Mean cell haemoglobin concentration normal, Mean cell haemoglobin normal, Mean cell volume normal
Clinical narrative: Pt "I have been having abd pain since Monday. I got my second shot for COIVD on Friday. I thought maybe I pulled a muscle from all the vomiting. It started uptop but now it is moved further down" Pt c/o SOB  ? Shortness of Breath This is a 45 y.o. male presenting today for evaluation of abdominal pain.  Patient says that he received his Covid-19 vaccine last Friday and he started to have symptoms.  He said that he at first was very tired and this progressed into abdominal pain, nausea and vomiting.  He also notes that he was having Taylor stools.  He says that he has not been eating as well.  He says that he has been nauseous much of this week and he started to have worsening abdominal pain in his upper abdomen down into his lower abdomen.  He denies any medical history other than high blood pressure which is not currently treated.  No history of any abdominal surgeries.  Patient denies any association with food
Age: 45.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Mean platelet volume normal, Platelet count normal, Protein C, Protein S, Red blood cell count normal
Clinical narrative: Pt "I have been having abd pain since Monday. I got my second shot for COIVD on Friday. I thought maybe I pulled a muscle from all the vomiting. It started uptop but now it is moved further down" Pt c/o SOB  ? Shortness of Breath This is a 45 y.o. male presenting today for evaluation of abdominal pain.  Patient says that he received his Covid-19 vaccine last Friday and he started to have symptoms.  He said that he at first was very tired and this progressed into abdominal pain, nausea and vomiting.  He also notes that he was having Taylor stools.  He says that he has not been eating as well.  He says that he has been nauseous much of this week and he started to have worsening abdominal pain in his upper abdomen down into his lower abdomen.  He denies any medical history other than high blood pressure which is not currently treated.  No history of any abdominal surgeries.  Patient denies any association with food
Age: 45.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Red cell distribution width normal, Scan with contrast abnormal, Thrombosis mesenteric vessel, Vomiting, White blood cell count abnormal
Clinical narrative: Pt "I have been having abd pain since Monday. I got my second shot for COIVD on Friday. I thought maybe I pulled a muscle from all the vomiting. It started uptop but now it is moved further down" Pt c/o SOB  ? Shortness of Breath This is a 45 y.o. male presenting today for evaluation of abdominal pain.  Patient says that he received his Covid-19 vaccine last Friday and he started to have symptoms.  He said that he at first was very tired and this progressed into abdominal pain, nausea and vomiting.  He also notes that he was having Taylor stools.  He says that he has not been eating as well.  He says that he has been nauseous much of this week and he started to have worsening abdominal pain in his upper abdomen down into his lower abdomen.  He denies any medical history other than high blood pressure which is not currently treated.  No history of any abdominal surgeries.  Patient denies any association with food
Age: 45.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Portal vein thrombosis, SARS-CoV-2 test
Clinical narrative: Pt "I have been having abd pain since Monday. I got my second shot for COIVD on Friday. I thought maybe I pulled a muscle from all the vomiting. It started uptop but now it is moved further down" Pt c/o SOB  ? Shortness of Breath This is a 45 y.o. male presenting today for evaluation of abdominal pain.  Patient says that he received his Covid-19 vaccine last Friday and he started to have symptoms.  He said that he at first was very tired and this progressed into abdominal pain, nausea and vomiting.  He also notes that he was having Taylor stools.  He says that he has not been eating as well.  He says that he has been nauseous much of this week and he started to have worsening abdominal pain in his upper abdomen down into his lower abdomen.  He denies any medical history other than high blood pressure which is not currently treated.  No history of any abdominal surgeries.  Patient denies any association with food
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Bradycardia, Chest discomfort, Chest pain, Troponin increased
Clinical narrative: Woke up at 3:30am with chest tightness/burning, pain in right area, clammy/sweaty, low HR (40-60bpm). Went to emergency room. Had an abdominal CT scan, EKG, Thoracic radiographs, cardiac ECHO, and lots of bloodwork performed. Results showed very elevated Troponin levels. Was told I had a heart attack as a healthy 27 year old. Later in the morning was told it was more likely myocarditis and was admitted into the hospital for 3 days/2nights. Monitored by an EKG for the duration of my stay and started taking blood thinners and Metoprolol. Troponin levels remained high for the duration of my stay but did peak on day 1 and start on a downward trend. Had a follow up MRI on 4/15 which was normal. Diagnoses is myocarditis due to Covid-19 vaccine. Will be having a cardiac CTA on 5/4 to make sure nothing is wrong with my arteries and confirm diagnosis.  Still currently taking Aspirin and Metoprolol daily and on exercise restriction for 2 months.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Chest X-ray, Chest discomfort, Chest pain, Cold sweat
Clinical narrative: Woke up at 3:30am with chest tightness/burning, pain in right area, clammy/sweaty, low HR (40-60bpm). Went to emergency room. Had an abdominal CT scan, EKG, Thoracic radiographs, cardiac ECHO, and lots of bloodwork performed. Results showed very elevated Troponin levels. Was told I had a heart attack as a healthy 27 year old. Later in the morning was told it was more likely myocarditis and was admitted into the hospital for 3 days/2nights. Monitored by an EKG for the duration of my stay and started taking blood thinners and Metoprolol. Troponin levels remained high for the duration of my stay but did peak on day 1 and start on a downward trend. Had a follow up MRI on 4/15 which was normal. Diagnoses is myocarditis due to Covid-19 vaccine. Will be having a cardiac CTA on 5/4 to make sure nothing is wrong with my arteries and confirm diagnosis.  Still currently taking Aspirin and Metoprolol daily and on exercise restriction for 2 months.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram abdomen, Echocardiogram, Electrocardiogram, Heart rate decreased, Hyperhidrosis
Clinical narrative: Woke up at 3:30am with chest tightness/burning, pain in right area, clammy/sweaty, low HR (40-60bpm). Went to emergency room. Had an abdominal CT scan, EKG, Thoracic radiographs, cardiac ECHO, and lots of bloodwork performed. Results showed very elevated Troponin levels. Was told I had a heart attack as a healthy 27 year old. Later in the morning was told it was more likely myocarditis and was admitted into the hospital for 3 days/2nights. Monitored by an EKG for the duration of my stay and started taking blood thinners and Metoprolol. Troponin levels remained high for the duration of my stay but did peak on day 1 and start on a downward trend. Had a follow up MRI on 4/15 which was normal. Diagnoses is myocarditis due to Covid-19 vaccine. Will be having a cardiac CTA on 5/4 to make sure nothing is wrong with my arteries and confirm diagnosis.  Still currently taking Aspirin and Metoprolol daily and on exercise restriction for 2 months.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging heart, Myocarditis
Clinical narrative: Woke up at 3:30am with chest tightness/burning, pain in right area, clammy/sweaty, low HR (40-60bpm). Went to emergency room. Had an abdominal CT scan, EKG, Thoracic radiographs, cardiac ECHO, and lots of bloodwork performed. Results showed very elevated Troponin levels. Was told I had a heart attack as a healthy 27 year old. Later in the morning was told it was more likely myocarditis and was admitted into the hospital for 3 days/2nights. Monitored by an EKG for the duration of my stay and started taking blood thinners and Metoprolol. Troponin levels remained high for the duration of my stay but did peak on day 1 and start on a downward trend. Had a follow up MRI on 4/15 which was normal. Diagnoses is myocarditis due to Covid-19 vaccine. Will be having a cardiac CTA on 5/4 to make sure nothing is wrong with my arteries and confirm diagnosis.  Still currently taking Aspirin and Metoprolol daily and on exercise restriction for 2 months.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Laboratory test, Laboratory test normal, Ocular hyperaemia
Clinical narrative: bleeding in the right eye, on the white part of the eye; headaches; This is a spontaneous report from a contactable consumer (patient). A 62-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number and expiry date unknown), via an unspecified route of administration on 27Mar2021 as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported that she had a headache two hours after the vaccine on 27Mar2021. On 29Mar2021 (reported as two or two and a half days after getting the first shot), she had bleeding in the right eye, on the white part of the eye. She was scheduled to get the second dose on 17Apr2021 and she is afraid and hesitant. She noticed the bleeding when she woke up in the morning, so the bleeding probably started at night. The blood was in the lower part of the right side of the eye and it was frightening. She read that side effects can be similar to flu like symptoms, but she didn't get any of those. She is concerned and both her Ophthalmologist and Primary care doctors both think that it will go away. The patient was worried because it never happened ever. She is afraid that with the second vaccine, the effects, will probably be stronger and wanted to know how protected she will be if she only takes the first vaccine. The outcome of the events was unknown.   Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Eye haemorrhage, Headache
Clinical narrative: bleeding in the right eye, on the white part of the eye; headaches; This is a spontaneous report from a contactable consumer (patient). A 62-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number and expiry date unknown), via an unspecified route of administration on 27Mar2021 as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported that she had a headache two hours after the vaccine on 27Mar2021. On 29Mar2021 (reported as two or two and a half days after getting the first shot), she had bleeding in the right eye, on the white part of the eye. She was scheduled to get the second dose on 17Apr2021 and she is afraid and hesitant. She noticed the bleeding when she woke up in the morning, so the bleeding probably started at night. The blood was in the lower part of the right side of the eye and it was frightening. She read that side effects can be similar to flu like symptoms, but she didn't get any of those. She is concerned and both her Ophthalmologist and Primary care doctors both think that it will go away. The patient was worried because it never happened ever. She is afraid that with the second vaccine, the effects, will probably be stronger and wanted to know how protected she will be if she only takes the first vaccine. The outcome of the events was unknown.   Information on the lot/batch number has been requested.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dehydration, Diarrhoea, Headache, Pyrexia
Clinical narrative: loss of consciousness plus all the normal symptoms; paralysis/partial paralysis; Fever of 103.7; diarrhea; nausea; dizzy; joint pain; migraine; throat swelling; nose swelling; eyes swelling; This is a spontaneous report received a contactable consumer, the patient. A 33-year-old adult [non-pregnant] female received the second dose of BNT162b2 (solution for injection; Lot ER8729 and expiry information not reported) in the right arm via unspecified route on 06Apr2021 at 09:45 (at 33 years-old) for COVID-19 immunisation. Relevant medical history included asthma, allergies, penicillin and adhesive tape allergies, and high blood pressure. Concomitant medications included lisinopril. The patient previously received COVID-19 immunisation with the first dose of BNT162b2 (Lot ER7531) in the right arm on 16Mar2021 at 09:45 (at 32-years-old). The patient previously received treatment for an unspecified indication with hydrocodone bitartrate/paracetamol (NORCO) and experienced an allergy. The denied being diagnosed with COVID-19 prior to the vaccine. The patient was not pregnant at time of vaccination, and the patient denied receiving any other vaccine within four weeks of this vaccine. On 06Apr2021 at 20:00 the patient experienced fever of 103.7, diarrhea, nausea, dizzy, paralysis, partial paralysis, joint pain, migraine, throat swelling, nose swelling, eyes swelling, loss of consciousness plus all the normal symptoms. The patient reported as a result of the events the patient sought care with a doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient was tested for COVID-19 since the vaccine with nasal swab test on 07Apr2021 and was negative. Treatment for the events received in the emergency room (ER) included diphenhydramine HCl (BENADRYL), ibuprofen, and acetaminophen (TYLENOL). The outcome of the events, fever of 103.7, diarrhea, nausea, dizzy, paralysis, partial paralysis, joint pain, migraine, throat swelling, nose swelling, eyes swelling, loss of consciousness plus all the normal symptoms, was not recovered.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Blood test normal, Diarrhoea, Epistaxis, Eye movement disorder
Clinical narrative: loss of consciousness plus all the normal symptoms; paralysis/partial paralysis; Fever of 103.7; diarrhea; nausea; dizzy; joint pain; migraine; throat swelling; nose swelling; eyes swelling; This is a spontaneous report received a contactable consumer, the patient. A 33-year-old adult [non-pregnant] female received the second dose of BNT162b2 (solution for injection; Lot ER8729 and expiry information not reported) in the right arm via unspecified route on 06Apr2021 at 09:45 (at 33 years-old) for COVID-19 immunisation. Relevant medical history included asthma, allergies, penicillin and adhesive tape allergies, and high blood pressure. Concomitant medications included lisinopril. The patient previously received COVID-19 immunisation with the first dose of BNT162b2 (Lot ER7531) in the right arm on 16Mar2021 at 09:45 (at 32-years-old). The patient previously received treatment for an unspecified indication with hydrocodone bitartrate/paracetamol (NORCO) and experienced an allergy. The denied being diagnosed with COVID-19 prior to the vaccine. The patient was not pregnant at time of vaccination, and the patient denied receiving any other vaccine within four weeks of this vaccine. On 06Apr2021 at 20:00 the patient experienced fever of 103.7, diarrhea, nausea, dizzy, paralysis, partial paralysis, joint pain, migraine, throat swelling, nose swelling, eyes swelling, loss of consciousness plus all the normal symptoms. The patient reported as a result of the events the patient sought care with a doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient was tested for COVID-19 since the vaccine with nasal swab test on 07Apr2021 and was negative. Treatment for the events received in the emergency room (ER) included diphenhydramine HCl (BENADRYL), ibuprofen, and acetaminophen (TYLENOL). The outcome of the events, fever of 103.7, diarrhea, nausea, dizzy, paralysis, partial paralysis, joint pain, migraine, throat swelling, nose swelling, eyes swelling, loss of consciousness plus all the normal symptoms, was not recovered.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Eye swelling, Fatigue, Loss of consciousness, Migraine, Muscular weakness
Clinical narrative: loss of consciousness plus all the normal symptoms; paralysis/partial paralysis; Fever of 103.7; diarrhea; nausea; dizzy; joint pain; migraine; throat swelling; nose swelling; eyes swelling; This is a spontaneous report received a contactable consumer, the patient. A 33-year-old adult [non-pregnant] female received the second dose of BNT162b2 (solution for injection; Lot ER8729 and expiry information not reported) in the right arm via unspecified route on 06Apr2021 at 09:45 (at 33 years-old) for COVID-19 immunisation. Relevant medical history included asthma, allergies, penicillin and adhesive tape allergies, and high blood pressure. Concomitant medications included lisinopril. The patient previously received COVID-19 immunisation with the first dose of BNT162b2 (Lot ER7531) in the right arm on 16Mar2021 at 09:45 (at 32-years-old). The patient previously received treatment for an unspecified indication with hydrocodone bitartrate/paracetamol (NORCO) and experienced an allergy. The denied being diagnosed with COVID-19 prior to the vaccine. The patient was not pregnant at time of vaccination, and the patient denied receiving any other vaccine within four weeks of this vaccine. On 06Apr2021 at 20:00 the patient experienced fever of 103.7, diarrhea, nausea, dizzy, paralysis, partial paralysis, joint pain, migraine, throat swelling, nose swelling, eyes swelling, loss of consciousness plus all the normal symptoms. The patient reported as a result of the events the patient sought care with a doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient was tested for COVID-19 since the vaccine with nasal swab test on 07Apr2021 and was negative. Treatment for the events received in the emergency room (ER) included diphenhydramine HCl (BENADRYL), ibuprofen, and acetaminophen (TYLENOL). The outcome of the events, fever of 103.7, diarrhea, nausea, dizzy, paralysis, partial paralysis, joint pain, migraine, throat swelling, nose swelling, eyes swelling, loss of consciousness plus all the normal symptoms, was not recovered.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Musculoskeletal stiffness, Myalgia, Neuralgia, Paralysis, Peripheral swelling
Clinical narrative: loss of consciousness plus all the normal symptoms; paralysis/partial paralysis; Fever of 103.7; diarrhea; nausea; dizzy; joint pain; migraine; throat swelling; nose swelling; eyes swelling; This is a spontaneous report received a contactable consumer, the patient. A 33-year-old adult [non-pregnant] female received the second dose of BNT162b2 (solution for injection; Lot ER8729 and expiry information not reported) in the right arm via unspecified route on 06Apr2021 at 09:45 (at 33 years-old) for COVID-19 immunisation. Relevant medical history included asthma, allergies, penicillin and adhesive tape allergies, and high blood pressure. Concomitant medications included lisinopril. The patient previously received COVID-19 immunisation with the first dose of BNT162b2 (Lot ER7531) in the right arm on 16Mar2021 at 09:45 (at 32-years-old). The patient previously received treatment for an unspecified indication with hydrocodone bitartrate/paracetamol (NORCO) and experienced an allergy. The denied being diagnosed with COVID-19 prior to the vaccine. The patient was not pregnant at time of vaccination, and the patient denied receiving any other vaccine within four weeks of this vaccine. On 06Apr2021 at 20:00 the patient experienced fever of 103.7, diarrhea, nausea, dizzy, paralysis, partial paralysis, joint pain, migraine, throat swelling, nose swelling, eyes swelling, loss of consciousness plus all the normal symptoms. The patient reported as a result of the events the patient sought care with a doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient was tested for COVID-19 since the vaccine with nasal swab test on 07Apr2021 and was negative. Treatment for the events received in the emergency room (ER) included diphenhydramine HCl (BENADRYL), ibuprofen, and acetaminophen (TYLENOL). The outcome of the events, fever of 103.7, diarrhea, nausea, dizzy, paralysis, partial paralysis, joint pain, migraine, throat swelling, nose swelling, eyes swelling, loss of consciousness plus all the normal symptoms, was not recovered.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pharyngeal swelling, Pruritus, Pyrexia, SARS-CoV-2 test negative, Sciatica
Clinical narrative: loss of consciousness plus all the normal symptoms; paralysis/partial paralysis; Fever of 103.7; diarrhea; nausea; dizzy; joint pain; migraine; throat swelling; nose swelling; eyes swelling; This is a spontaneous report received a contactable consumer, the patient. A 33-year-old adult [non-pregnant] female received the second dose of BNT162b2 (solution for injection; Lot ER8729 and expiry information not reported) in the right arm via unspecified route on 06Apr2021 at 09:45 (at 33 years-old) for COVID-19 immunisation. Relevant medical history included asthma, allergies, penicillin and adhesive tape allergies, and high blood pressure. Concomitant medications included lisinopril. The patient previously received COVID-19 immunisation with the first dose of BNT162b2 (Lot ER7531) in the right arm on 16Mar2021 at 09:45 (at 32-years-old). The patient previously received treatment for an unspecified indication with hydrocodone bitartrate/paracetamol (NORCO) and experienced an allergy. The denied being diagnosed with COVID-19 prior to the vaccine. The patient was not pregnant at time of vaccination, and the patient denied receiving any other vaccine within four weeks of this vaccine. On 06Apr2021 at 20:00 the patient experienced fever of 103.7, diarrhea, nausea, dizzy, paralysis, partial paralysis, joint pain, migraine, throat swelling, nose swelling, eyes swelling, loss of consciousness plus all the normal symptoms. The patient reported as a result of the events the patient sought care with a doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient was tested for COVID-19 since the vaccine with nasal swab test on 07Apr2021 and was negative. Treatment for the events received in the emergency room (ER) included diphenhydramine HCl (BENADRYL), ibuprofen, and acetaminophen (TYLENOL). The outcome of the events, fever of 103.7, diarrhea, nausea, dizzy, paralysis, partial paralysis, joint pain, migraine, throat swelling, nose swelling, eyes swelling, loss of consciousness plus all the normal symptoms, was not recovered.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Swelling, Throat irritation
Clinical narrative: loss of consciousness plus all the normal symptoms; paralysis/partial paralysis; Fever of 103.7; diarrhea; nausea; dizzy; joint pain; migraine; throat swelling; nose swelling; eyes swelling; This is a spontaneous report received a contactable consumer, the patient. A 33-year-old adult [non-pregnant] female received the second dose of BNT162b2 (solution for injection; Lot ER8729 and expiry information not reported) in the right arm via unspecified route on 06Apr2021 at 09:45 (at 33 years-old) for COVID-19 immunisation. Relevant medical history included asthma, allergies, penicillin and adhesive tape allergies, and high blood pressure. Concomitant medications included lisinopril. The patient previously received COVID-19 immunisation with the first dose of BNT162b2 (Lot ER7531) in the right arm on 16Mar2021 at 09:45 (at 32-years-old). The patient previously received treatment for an unspecified indication with hydrocodone bitartrate/paracetamol (NORCO) and experienced an allergy. The denied being diagnosed with COVID-19 prior to the vaccine. The patient was not pregnant at time of vaccination, and the patient denied receiving any other vaccine within four weeks of this vaccine. On 06Apr2021 at 20:00 the patient experienced fever of 103.7, diarrhea, nausea, dizzy, paralysis, partial paralysis, joint pain, migraine, throat swelling, nose swelling, eyes swelling, loss of consciousness plus all the normal symptoms. The patient reported as a result of the events the patient sought care with a doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient was tested for COVID-19 since the vaccine with nasal swab test on 07Apr2021 and was negative. Treatment for the events received in the emergency room (ER) included diphenhydramine HCl (BENADRYL), ibuprofen, and acetaminophen (TYLENOL). The outcome of the events, fever of 103.7, diarrhea, nausea, dizzy, paralysis, partial paralysis, joint pain, migraine, throat swelling, nose swelling, eyes swelling, loss of consciousness plus all the normal symptoms, was not recovered.